CAS Number: 137-58-6
Compatible with breastfeeding no matter the multiple ways it can be used: anesthetic, anti-arrhythmic, or anti-epileptic drug. Excreted into breast milk in non-significant amount with no side effects on breastfed infants from treated mothers. As a topical anesthetic (dermatologic, dental-stomatologic, ophtalmotologic and otologic preparations) it has an almost nil systemic absorption. Avoid using it on the nipple, but if necessary do it after the breast feed, wipe it out and rinse with water before the next feed, An euptectic mixture with added Prilocaine (EMLA) is used for dermatologic anesthesia. There is an increased risk of Methemoglobinemia when applied on large surfaces or taken by mouth. Intrapartum anesthesia may delay the onset of phase II of Lactogenesis or milk coming-in. The American Academy of Pediatrics rates it usually compatible with Breastfeeding.
Herb which is widely used by many cultures. It has been used even for pain relief during pregnancy and colicky pain in fussy babies (without proved data on this). Since it is non toxic at appropriate dose and a tiny excretion into breast milk of active metabolite Menthol, a moderate consumption is believed compatible while breastfeeding. Dessicated leaves and essential oil of the plant that contains Menthol are used. Properties that have been demonstrated and approved indications are: as spasmolytic for Dyspepsia, Irritable Colon and flatulence. It has been used for the treatment of cracked nipple with best results than placebo or Lanolin. Although with no proven effectiveness, it is traditionally used for cough relief, common cold, pain or itching by local application or inhalation. Overdosing of essential oil may be harmful. Do not expose infants to inhalation of products that contain Menthol (irritation of the air way) In case of use on the nipple, do it after feeding the baby and cleanse thoroughly the surface before the next one.
CAS Number: 69-72-7
It is topically used as a keratolytic, antiseptic, antifungal, dermatological and stomatological agent. At last update no published data on excretion into breast milk were found . Systemic absorption (distribution into the body) depends on the concentration of the product used and the duration of application. Absorption may reach 10 to 25% of the total amount applied on the skin. It is recommended not to use during lactation in large areas of skin or for prolonged periods. Available data on the elimination of Acetylsalicylic acid (Aspirin-ASA) in breast milk indicates it is clinically insignificant.No cases have been reported on Reye's syndrome by ASA through the breast milk which is considered very unlikely to occur with isolated and/or small doses used as antithrombotic treatments and anti-abortion measures, even less after application on the skin or topically in the mouth. Do not apply on the breast to prevent ingestion by the infant. If necessary, apply it after the feed and wipe it off thoroughly with water before the next feed.
CAS Number: 137-58-6
Lidocaine concentrations in milk during continuous IV infusion, epidural administration and in high doses as a local anesthetic are low and the lidocaine is poorly absorbed by the infant. Lidocaine is not expected to cause any adverse effects in breastfed infants. No special precautions are required. Lidocaine labor and delivery with other anesthetics and analgesics has been reported by some to interfere with breastfeeding. However, this assessment is controversial and complex because of the many different combinations of drugs, dosages and patient populations studied as well as the variety of techniques used and deficient design of many of the studies. Overall it appears that with good breastfeeding support epidural lidocaine with or without fentanyl or one of its derivatives has little or no adverse effect on breastfeeding success. Labor pain medication may delay the onset of lactation.
Peppermint (Mentha x piperita) contains menthol, menthone, menthyl acetate as major ingredients. Minor ingredients include 1,8-cineole, pulegone, bitter substances, caffeic acid, flavonoids, and tannins. Peppermint is a purported galactogogue; however, no scientifically valid clinical trials support this use. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production. Topical peppermint gel and solutions have been studied for the prevention of pain and cracked nipples and areolas in nursing women. The peppermint preparations were more effective than placebo and expressed breastmilk, and about as effective as lanolin, although a meta-analysis concluded that application of nothing or breastmilk may be superior to lanolin, but good studies are lacking. Menthol is excreted into breastmilk in small quantities; the excretion of other components have not been studied. Peppermint is "generally recognized as safe" (GRAS) as a food by the U.S. Food and Drug Administration. Large doses can cause heartburn, nausea and vomiting. Allergic reactions, including headache, have been reported to menthol. If peppermint is used on the nipples, it should be used after nursing and wiped off before the next nursing. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 69-72-7
No information is available on the clinical use of salicylic acid on the skin during breastfeeding. Because it is unlikely to be appreciably absorbed or appear in breastmilk, it is considered safe to use during breastfeeding. Avoid application to areas of the body that might come in direct contact with the infant's skin or where the drug might be ingested by the infant via licking.
Velma Pain Relief Patch Lidocaine 4 G, Menthol 2 G, Methyl Salicylate 16 G is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Velma Pain Relief Patch Lidocaine 4 G, Menthol 2 G, Methyl Salicylate 16 G you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.
Usage of Velma Pain Relief Patch Lidocaine 4 G, Menthol 2 G, Methyl Salicylate 16 G is safe for nursing mothers and baby, No worries.
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week